Meta-Analysis
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Mar 27, 2016; 8(3): 274-283
Published online Mar 27, 2016. doi: 10.4240/wjgs.v8.i3.274
Table 1 Study characteristics
Ref.CountryDateTypenNOS (0-9)Pre-operative infliximab use (w)Age1Sex (m)SteroidsAbscess
Appau et al[7]United States1998-2007Retrospective cohort389712
Infliximab35.8 (11.9)48.3%65%38%
No infliximab36.8 (14.4)45.9%77%44%
Canedo et al[10]United States2000-2008Retrospective cohort225712
Infliximab26 (24.9-43.6)44%NS37%
No infliximab32 (29.4-41.9)51%NS30%
Colombel et al[11]United States1998-2001Retrospective cohort27078
InfliximabNSNS36%NS
No infliximabNSNS42%NS
El Hussuna et al[17]Denmark2000-2007Retrospective cohort369712
Infliximab33 (18-62)NSNS34%
No infliximab37 (8-90)NSNS19%
Kasparek et al[15]Munich2001-2008Case control match96712
Infliximab35 (17-66)43%94%NS
No infliximab39 (17-68)50%94%NS
Kotze et al[23]Brazil2007-2010Retrospective cohort7674
InfliximabNSNSNSNS
No infliximabNSNSNSNS
Marchal et al[18]Netherlands1998-2002Case control match68812
Infliximab36 (16-73)NS35%50%
No infliximab38.7 (17-63)NS35%41%
Mascarenhas et al[16]United States2003-2010Retrospective cohort93612
Infliximab35.6 (14.1)42%68%NS
No infliximab37 (14.1)60%44%NS
Myrelid et al[21]Europe1989-2002Retrospective cohort29868
InfliximabNS46%NS20%
No infliximabNS36%NS20%
Nasir et al[20]United States2005-2008Retrospective cohort37088
Infliximab38.2 (17-66)43%31%NS
No infliximab43.3 (17-77)41%45%NS
Nørgård et al[9]Denmark2000-2010Retrospective cohort2293612
InfliximabNS45%9%NS
No infliximabNS41%14%NS
Syed et al[8]United States2004-2011Retrospective cohort32578
Infliximab38.2 (13.9)34%40%8%
No infliximab40 (14.3)45%35%9%
Tay et al[19]United States1998-2002Retrospective cohort10078
InfliximabNSNS0%NS
No infliximabNSNS18%NS
Uchino et al[22]Japan2008-2011Retrospective cohort405712
Infliximab36 (14-72)73%37%NS
No infliximab37 (16-78)69%34%NS
Total5377